We are offering Pharma Packaging. One of the most vibrant industries, pharmaceuticals packaging is slated to increase and witness an annual growth of 5.5% and in 2014, the demand will reach $20 billion in the usa. Likewise the same demand is slated to ricochet across the world as countries tighten their quality norms and upgrade regulations and standards concerning infection control, barrier protection, drug dispensing errors, drug diversion and patient drug compliance. Concern for these and strict adherence to the same will result in the growth of high quality containers and related accessories and consequently, quality packaging materials.
pharmaceutical pouches and pre-fillable inhalers will see more rapid growth as it will corner a greater market share than ever, all of it thanks to the forecast enormous growth of the number of asthmatic and allergic patients. New therapies and innovations that are regularly occurring in the research arena will be another driving force behind the growing demand for quality pharmaceutical packaging and consequently, equally phenomenal demand for quality packaging materials.
a good quality pharma packaging material must meet the criteria of product protection, quality; tamper evidence, patient comfort and security needs. N b polyfilms not only possess the capability to meet all of these requirements but also has the ability to set new trends that sets new benchmarks for the industry to follow.
high on innovation, n b polyfilms harnesses the latest technologies and leverages its proven competency to consistently provide a diverse range of quality pharma packaging materials for the medical, pharmaceutical and life science markets and address compliance and counterfeit concerns.
Good packaging needs good packaging materials that provide stability, adaptability and longer shelf life to the drug and the delivery system, further ensuring the safety and convenience of drug use. we are well placed to provide sustained quality packaging solutions that cater to the complex needs of the pharmaceutical industry.

We are offering Pharma Packaging. One of the most vibrant industries, pharmaceuticals packaging is slated to increase and witness an annual growth of 5.5% and in 2014, the demand will reach $20 billion in the usa. Likewise the same demand is slated to ricochet across the world as countries tighten their quality norms and upgrade regulations and standards concerning infection control, barrier protection, drug dispensing errors, drug diversion and patient drug compliance. Concern for these and strict adherence to the same will result in the growth of high quality containers and related accessories and consequently, quality packaging materials.
pharmaceutical pouches and pre-fillable inhalers will see more rapid growth as it will corner a greater market share than ever, all of it thanks to the forecast enormous growth of the number of asthmatic and allergic patients. New therapies and innovations that are regularly occurring in the research arena will be another driving force behind the growing demand for quality pharmaceutical packaging and consequently, equally phenomenal demand for quality packaging materials.
a good quality pharma packaging material must meet the criteria of product protection, quality; tamper evidence, patient comfort and security needs. N b polyfilms not only possess the capability to meet all of these requirements but also has the ability to set new trends that sets new benchmarks for the industry to follow.
high on innovation, n b polyfilms harnesses the latest technologies and leverages its proven competency to consistently provide a diverse range of quality pharma packaging materials for the medical, pharmaceutical and life science markets and address compliance and counterfeit concerns.
Good packaging needs good packaging materials that provide stability, adaptability and longer shelf life to the drug and the delivery system, further ensuring the safety and convenience of drug use. we are well placed to provide sustained quality packaging solutions that cater to the complex needs of the pharmaceutical industry.